poster

Treatment Patterns From OASIS: Observational Study of Long-Acting Injectables in Schizophrenia

OASIS was a 12-month observational study evaluating real-world outcomes of atypical long-acting injectable (aLAI) antipsychotics in patients with schizophrenia. Most patients initiated aL...

10/26/2023

TV-46000—a Long-Acting Subcutaneous Antipsychotic (LASCA) for the Treatment of Schizophrenia: Local Tolerability and Injection Site Reactions

TV-46000 is a long-acting subcutaneous antipsychotic (LASCA) that combines risperidone and an innovative delivery technology in a suspension suitable for subcutaneous administration in th...

10/26/2023

Understanding Patient Profiles among Medicaid Patients with Treatment-resistant Depression Initiated on Esketamine

Real-world data studies on esketamine use for treatment-resistant depression (TRD) in the US have previously focused on commercially-insured patients. In this study of Medicaid beneficiar...

10/26/2023

Understanding Profiles of Patients with Treatment-resistant Depression by Stringency of Health Plan Prior Authorization Criteria for Approval of Esketamine

In the United States, some health plans have more stringent prior authorization (PA) criteria for esketamine insurance coverage for treatment-resistant depression (TRD), requiring more th...

10/26/2023

Understanding the Experiences of Patients With Major Depressive Disorder Treated With Zuranolone: Qualitative Interviews With Participants From the Open-Label SHORELINE Study

Researchers conducted qualitative interviews to understand patients’ experiences with and perceptions of zuranolone, an oral, investigational, once-daily, 14-day treatment course in clini...

10/26/2023

Understanding the Independent Impact of Social Determinants of Health on Resource Utilization and Health Outcomes in Civilian Post-Traumatic Stress Disorder: A Real-World Evidence Analysis

This study assesses the independent impact of social determinants of health and presence of post-traumatic stress disorder on resource utilization and health outcomes in civilians with po...

10/26/2023

Transforming Mental Healthcare Amidst Conflict: TeleHelp Ukraine's Telemedicine Services During The Russian Invasion Of Ukraine

Discover how TeleHelp Ukraine revolutionizes mental health care amidst the crisis caused by the Russian invasion. This non-profit utilizes telemedicine, offering secure video consultation...

10/26/2023

Transitioning Patients to Long-Acting Injectable Antipsychotics: Attitudes and Perceptions of US Clinicians Based on a Hypothetical Case (Results From the DECIDE Survey)

This analysis presents the opinions of US-practicing psychiatric clinicians on a hypothetical case where a psychiatrist introduces the topic of transitioning to a long-acting injectable a...

10/26/2023

The Relationship Between Therapist Adverse Childhood Experiences, Personal Therapy, Resilience, and Treatment Outcomes

A dissertation exploring the relationships between therapist adverse childhood experiences, personal therapy, resilience, therapeutic alliance, and treatment outcomes.

10/26/2023

The Role of Emotion Dysregulation and Pain-endurance in Non-suicidal Self-injury and Disordered Eating Behaviors

This poster shows the interactive relationship between physical pain endurance and emotion dysregulation as predictors for risky behaviors such as NSSI and disordered eating/exercising. ...

10/26/2023

Tracks

Major Depressive Disorder

General Psychiatry

ADHD

MDD Insights

Schizophrenia Insights

About

Celebrating 35 years of empowering the highest standard in mental healthcare, Psych Congress serves as a unique, integrated forum to connect members of the entire mental health team—bringing together psychiatrists, nurse practitioners, physician assistants, psychologists, primary care physicians, and other mental health professionals for 4 days of practical education to improve patient care.